Cargando…

654. Evaluation of the Febridx Host Response Point-of-Care Test to Differentiate Viral From Bacterial Etiology in Adults Hospitalized with Acute Respiratory Illness During Influenza Season

BACKGROUND: Antibiotics are overused in patients hospitalized with acute respiratory illness (ARI). Diagnostic uncertainty regarding microbial etiology contributes to this practice and so a host response test that can distinguish between viral and bacterial infection has the potential to reduce unne...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beard, Kate, Chan, Cathleen, Mills, Samuel, Poole, Stephen, Brendish, Nathan, Clark, Tristan William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811072/ http://dx.doi.org/10.1093/ofid/ofz360.722

Ejemplares similares

Pragmatic multicentre randomised controlled trial evaluating the impact of a routine molecular point-of-care ‘test-and-treat’ strategy for influenza in adults hospitalised with acute respiratory illness (FluPOC): trial protocol
por: Beard, Kate, et al.
Publicado: (2019)

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department
por: Mansbridge, Christopher T., et al.
Publicado: (2022)

Diagnostic accuracy of the FebriDx host response point-of-care test in patients hospitalised with suspected COVID-19
por: Clark, Tristan W., et al.
Publicado: (2020)

FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department – ADDENDUM
por: Mansbridge, Christopher T., et al.
Publicado: (2022)

120. Impact of a Molecular Point-of-care ‘test and Treat’ Strategy for Influenza in Hospitalised adults: A Multi-centre, Randomised Controlled Trial (FluPOC)
por: Clark, Tristan William, et al.
Publicado: (2020)

Clinical impact of a routine, molecular, point-of-care, test-and-treat strategy for influenza in adults admitted to hospital (FluPOC): a multicentre, open-label, randomised controlled trial
por: Clark, Tristan W, et al.
Publicado: (2021)

1717. The Impact of Routine Molecular Point-of-care Testing for Gastrointestinal Pathogens in Adults Hospitalized With Suspected Gastroenteritis: Results of a Pragmatic Randomized Controlled Trial (GastroPOC)
por: Malachira, Ahalya, et al.
Publicado: (2018)

SARS-CoV-2 viral load at presentation to hospital is independently associated with the risk of death
por: Tanner, Alex R, et al.
Publicado: (2021)

SARS-CoV-2 has displaced other seasonal respiratory viruses: Results from a prospective cohort study
por: Poole, Stephen, et al.
Publicado: (2020)

2796. The Impact of Syndromic Molecular Point-of-Care Testing for Respiratory Viruses on Antibiotic Use in Adults Presenting to Hospital with Exacerbation of Airways Disease: Further Analysis From a Randomized Controlled Trial
por: Clark, Tristan William, et al.
Publicado: (2019)

Impact of point-of-care testing for respiratory viruses on antibiotic use in adults with exacerbation of airways disease
por: Brendish, Nathan J., et al.
Publicado: (2019)

Viral etiology and seasonality of influenza-like illness in Gabon, March 2010 to June 2011
por: Lekana-Douki, Sonia Etenna, et al.
Publicado: (2014)

Molecular point-of-care testing for respiratory viruses versus routine clinical care in adults with acute respiratory illness presenting to secondary care: a pragmatic randomised controlled trial protocol (ResPOC)
por: Brendish, Nathan J., et al.
Publicado: (2017)

Combined RT-PCR and Host Response Point-of-Care Testing in Patients Hospitalised with Suspected COVID-19: A Prospective Diagnostic Accuracy Study
por: Brendish, Nathan J., et al.
Publicado: (2022)

Diagnostic Accuracy of FebriDx: A Rapid Test to Detect Immune Responses to Viral and Bacterial Upper Respiratory Infections
por: Self, Wesley H., et al.
Publicado: (2017)

FebriDx(®): A Rapid Diagnostic Test for Differentiating Bacterial and Viral Aetiologies in Acute Respiratory Infections
por: Shirley, Matt
Publicado: (2019)

Economic Evaluation of FebriDx®: A Novel Rapid, Point-of-Care Test for Differentiation of Viral versus Bacterial Acute Respiratory Infection in the United States
por: Dick, Katherine, et al.
Publicado: (2021)

Point-of-care testing for respiratory viruses in adults: The current landscape and future potential
por: Brendish, Nathan J., et al.
Publicado: (2015)

Influenza vaccination: protecting the most vulnerable
por: Tanner, Alex R., et al.
Publicado: (2021)

Utility of the FebriDx point‐of‐care test for rapid triage and identification of possible coronavirus disease 2019 (COVID‐19)
por: Karim, Nawazish, et al.
Publicado: (2020)

Physical distancing in schools for SARS-CoV-2 and the resurgence of rhinovirus
por: Poole, Stephen, et al.
Publicado: (2020)

Routine molecular point-of-care testing for SARS-CoV-2 reduces hospital-acquired COVID-19
por: Livingstone, Robert, et al.
Publicado: (2022)

Viral etiologies of influenza‐like illness and severe acute respiratory infections in Thailand
por: Chittaganpitch, Malinee, et al.
Publicado: (2018)

Viral etiology of influenza-like illnesses in Huizhou, China, from 2011 to 2013
por: Ju, Xiongfei, et al.
Publicado: (2014)

Increase in circulation of non-SARS-CoV-2 respiratory viruses following easing of social distancing is associated with increasing hospital attendance
por: Tanner, Alex R, et al.
Publicado: (2021)

Utility of the FebriDx point-of-care assay in supporting a triage algorithm for medical admissions with possible COVID-19: an observational cohort study
por: Houston, Hamish, et al.
Publicado: (2021)

Viral Etiology of Influenza-Like Illnesses in Antananarivo, Madagascar, July 2008 to June 2009
por: Razanajatovo, Norosoa Harline, et al.
Publicado: (2011)

Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial
por: Brendish, Nathan J, et al.
Publicado: (2017)

2023. A Prospective, Multi-Center U.S. Clinical Trial to Determine Accuracy of FebriDx Point-of-Care Testing for Acute Upper Respiratory Infections with and Without a Confirmed Fever
por: Sambursky, Robert, et al.
Publicado: (2018)

Self-medication and ILI etiologies among individuals presenting at pharmacies with influenza-like illness: Guatemala City, 2018 influenza season
por: Ramay, Brooke M., et al.
Publicado: (2022)

Viral influenza-like illnesses: dynamic interrelationships during the 2015–2016 influenza season in hospitalized patients
por: Cunha, B.A.
Publicado: (2017)

Epidemiological analysis of respiratory viral etiology for influenza-like illness during 2010 in Zhuhai, China
por: Li, Hongxia, et al.
Publicado: (2013)

415. Clinical Impact of Molecular Point-of-Care Testing for COVID-19 in Adults Presenting to Hospital: A Prospective, Interventional, Non-Randomised, Controlled Study
por: Brendish, Nathan J, et al.
Publicado: (2020)

The intersection of viral illnesses: A seasonal influenza epidemic amidst the COVID-19 pandemic
por: Ehrlich, Haley, et al.
Publicado: (2020)

Viral etiology and seasonal trends of pediatric acute febrile illness in southern Puerto Rico; a seven-year review
por: Sánchez-González, Liliana, et al.
Publicado: (2021)

Bacterial lipodipeptide, Lipid 654, is a microbiome-associated biomarker for multiple sclerosis
por: Farrokhi, Vahid, et al.
Publicado: (2013)

Re: 'Syndromic panels or “panel syndrome”? A perspective through the lens of respiratory-tract infections' by Zanella et al
por: Brendish, N.J., et al.
Publicado: (2020)

Multiple viral etiologies in patients with influenza-like illness and severe acute respiratory infection in Qatar, 2013–2016
por: Nadeem, Shazia, et al.
Publicado: (2020)

Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy
por: Lagi, Filippo, et al.
Publicado: (2021)

Transmission Media Characteristics : Recommendations G.601-G.654
por: International Telegraph and Telephone Consultative Committee. Geneva, et al.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_kio01tcmioo6vitug6nmr0tm9l